Multikinase inhibitors for treating high-risk myelodysplastic syndromes: can this be brought into clinical practice? | Aplastic Anemia & MDS International Foundation Return to top.

Multikinase inhibitors for treating high-risk myelodysplastic syndromes: can this be brought into clinical practice?

Journal Title: 
Expert Rev Hematol
Primary Author: 
Duong VH
Author(s): 
Duong VH, Padron E, List AF, Komrokji RS.
Original Publication Date: 
Wednesday, October 2, 2013

No abstract available.

Bone Marrow Disease(s): 
  • myelodysplastic syndromes (MDS)
Share with addtoany.com.